NET-Inhibition with Ampreloxetine, Blood Pressure, and Catecholamines in Patients with Neurogenic Orthostatic Hypotension (S9.001)
To determine the impact of ampreloxetine (oral, 10 mg/day) on orthostatic blood pressures (BP) and venous norepinephrine levels in patients with alpha-synucleinopathies.
Authors
- Meredith Bryarly (ORCID: https://orcid.org/0000-0002-3867-9309)
- Italo Biaggioni (ORCID: https://orcid.org/0000-0001-7667-7083)
- Lucy Norcliffe‐Kaufmann (ORCID: https://orcid.org/0000-0003-0702-1333)
- Valeria Iodice
- Horacio Kaufmann (ORCID: https://orcid.org/0000-0002-1851-9981)
- Ross G. Vickery
- Tadhg Geurin
Institutions
- NYU Langone Health (US)
- Southwestern Medical Center (US)
- Theravance Biopharma (United States) (US)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212132
- Primary Topic
- Cardiovascular Syncope and Autonomic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00